Cart
sales@molnova.com
Loreclezole
CAS No. 117857-45-1
Loreclezole( —— )
Catalog No. M20110 CAS No. 117857-45-1
Loreclezole is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit-containing receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 32 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 98 | In Stock |
|
| 50MG | 178 | In Stock |
|
| 100MG | 265 | In Stock |
|
| 200MG | 377 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLoreclezole
-
NoteResearch use only, not for human use.
-
Brief DescriptionLoreclezole is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit-containing receptors.
-
DescriptionLoreclezole is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit-containing receptors.
-
In Vitro——
-
In VivoLoreclezole (10, 25, 50 or 75 mg/kg, i.p. 60 min before measurement of seizure threshold ) results in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. Loreclezole also has the least effect on loss of muscle tone as measured by the “pull-up” test. Animal Model:Adult male Lister Hooded rats.Dosage:10, 25, 50 or 75 mg/kg.Administration:IP, 60 min before measurement of seizure threshold.Result:Resulted in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABAA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number117857-45-1
-
Formula Weight274.53
-
Molecular FormulaC10H6Cl3N3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL (327.83 mM)
-
SMILESCl\C(=C/n1cncn1)c1ccc(Cl)cc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Donnelly JL et al. Loreclezole enhances apparent desensitization of recombinant GABAA receptor currents. Neuropharmacology. 1996;35(9-10):1233-41.
molnova catalog
related products
-
Z16078526
Z16078526 enhances thermogenesis in mice by inducing endogenous Ucp1 expression, promoting p38 MAPK phosphorylation, and stimulating lipolysis in primary mouse brown adipocytes.
-
Corticotropin-releas...
Corticotropin-releasing factor human (Human CRF; Human corticotropin-releasing factor) is an immunomodulatory neuropeptide that acts to release ACTH from the anterior pituitary and stimulates the sympathetic nervous system and adrenal medulla. Functions by reducing hyperpolarizations. Acts as a functional antagonist of inflammatory mediators.
-
Glucocapparin
The herbs of Capparis spinosa L.
